FindTrial
Sign In

Use of Vitamin D supplementation on BP control in Vitamin D deficient patients.

Appropriateness of Vitamin D supplementation as an adjunct therapy in hypertensive patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016734
Enrollment
50
Registered
2018-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10-I16- Hypertensive diseases Health Condition 2: E559- Vitamin D deficiency, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Adwaetha Nambiar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Induviduals with hypertension (newly diagnosed or on mono or dual therapy 2.vitamin D deficient

Exclusion criteria

Exclusion criteria: 1.patients not willing to give consent 2.incomplete follow up data 3.patients on more than two antihypertensive medication 4.patients who are not tested for vitamin d deficiency. 5. patients who are already o vitamin D supplementation for a period of more than a month . 6. Patient expired during the study period

Design outcomes

Primary

MeasureTime frame
BPTimepoint: on the day of enrollment and after 8 weeks when patient comes for followup—

Secondary

MeasureTime frame
urea , serum creatinine,sodium, potassium , calciumTimepoint: on the day of enrollment and after 8 weeks—

Countries

India

Contacts

Public ContactMrJohn Preshanth K

Manipal college of pharmaceutical sciences

adwaetha.nambiar@gmail.com7829855455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026